Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11642390 | Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody | Panayiotis Stevis, Andrew J. Murphy, Jesper Gromada, Yonaton Ray, Jee H. Kim | 2023-05-09 |
| 11104730 | Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors | Jingtai Cao, Eunice Cheung | 2021-08-31 |
| 11071780 | Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab | Robert L. Vitti, Kristine A. Erickson, Karen Chu, Stanley Wiegand, Jingtai Cao +3 more | 2021-07-27 |
| 10947310 | Fusion protein comprising apelin and an anti-APLNR antibody | Panayiotis Stevis, Andrew J. Murphy, Jesper Gromada, Yonaton Ray, Jee H. Kim | 2021-03-16 |
| 10626173 | Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR | Panayiotis Stevis, Jesper Gromada, Andrew J. Murphy, Yonaton Ray, Jee H. Kim | 2020-04-21 |
| 10189901 | Methods for improving cardiac function by administering an antibody that activates APLNR | Panayiotis Stevis, Andrew J. Murphy, Jesper Gromada, Yonaton Ray, Jee H. Kim | 2019-01-29 |
| 10155811 | APLNR modulators and uses thereof | Panayiotis Stevis, Jesper Gromada, Andrew J. Murphy, Yonaton Ray, Jee H. Kim | 2018-12-18 |
| 10023642 | Anti-PDGFR-beta antibodies and uses thereof | Stanley Wiegand | 2018-07-17 |
| 9650444 | Anti-PDGFR-beta antibodies and uses thereof | Stanley Wiegand | 2017-05-16 |
| 9644018 | Antibody modulators of APLNR | Panayiotis Stevis, Andrew J. Murphy, Jesper Gromada, Yonaton Ray, Jee H. Kim | 2017-05-09 |
| 9265827 | Anti-PDGFR-beta antibodies and uses thereof | Stanley Wiegand | 2016-02-23 |
| 7488573 | In vivo angiogenesis assay | Richard A. Lang | 2009-02-10 |